Latest Breaking News On - Oricell therapeutics - Page 1 : comparemela.com

Artios Pharma Bolsters Board of Directors with Appointment of Chris Liu, PhD

CAMBRIDGE, United Kingdom and NEW YORK, April 09, 2024 (GLOBE NEWSWIRE) Artios Pharma Limited (“Artios”), clinical-stage biotech company led .

United kingdomCity ofNiall martinTim mccarthyChris liuMerck kgaArix bioscienceSenior research analystCancer research united kingdomInstitute of cancer researchArtios pharma limitedCrick instituteMaster of business administrationBusiness development at genscriptBiotech opportunities ltdNetherlands cancer institute

Artios Pharma Bolsters Board of Directors with Appointment

Artios Strengthens Board of Directors with Appointment of RTW Investments’ Chris Liu, Ph.D..

City ofUnited kingdomChris liuNiall martinTim mccarthyArtios pharma limitedCrick instituteMaster of business administrationBusiness development at genscriptMerck kgaArix bioscienceCancer research united kingdomSenior research analystInstitute of cancer researchArtios pharma ltdMerck kgaa

Oricell Obtained FDA IND Clearance of OriCAR-017, a Novel GPRC5D Targeted CAR-T Cell Therapy for R/R MM

BioPharma

Helen yangDrug administrationOricell therapeuticsInvestigational new drugInvestigator initiated trialChief scientific officerChief executive officer

Flagship CEO says firm has work to do before inking China pacts

Flagship CEO says firm has work to do before inking China pacts
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Ji xingCity ofUnited kingdomSouth koreaNoubar afeyanFierce biotechHealthcare conferenceOricell therapeuticsThermo fischer

Relapsing Refractory Multiple Myeloma Pipeline Report, 2023 Updates: In-depth Analysis into the Clinical Trials, Latest FDA, EMA, and PMDA Approvals, Emerging Drugs, and Growth Prospects | Novartis, Gilead Sciences, Arcellx, Inc , Pfizer, Bristol-Myers Squibb |

Relapsing Refractory Multiple Myeloma Pipeline Report, 2023 Updates: In-depth Analysis into the Clinical Trials, Latest FDA, EMA, and PMDA Approvals, Emerging Drugs, and Growth Prospects | Novartis, Gilead Sciences, Arcellx, Inc , Pfizer, Bristol-Myers Squibb |
medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomArtiva biotherapeuticsGaurav boraBristol myers squibbLas vegasHealthcare consulting servicesGilead sciencesCellectar biosciences incBinco incDrug administrationUniversity collaborations licensing partnering analysisGilead companyMyeloma route of administrationIchnos sciencesMyeloma key companies